| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A71883111 |
| PharmacoGx | BRD-A71883111 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NRSN1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | CERS6 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | CNTN4 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PCDHGA8 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | FRMD6 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | B3GNT9 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | MAP3K7CL | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | ZMYND8 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | DAGLB | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | RASSF2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
